NeoPharm Co (XKRX:092730) 3-Year EBITDA Growth Rate : 8.60% (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co 3-Year EBITDA Growth Rate?

NeoPharm Co's EBITDA per Share for the three months ended in Sep. 2024 was ₩404.76.

During the past 12 months, NeoPharm Co's average EBITDA Per Share Growth Rate was 7.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 8.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 24.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of NeoPharm Co was 60.10% per year. The lowest was -45.80% per year. And the median was 11.45% per year.

Competitive Comparison of NeoPharm Co's 3-Year EBITDA Growth Rate

For the Household & Personal Products subindustry, NeoPharm Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeoPharm Co's 3-Year EBITDA Growth Rate Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's 3-Year EBITDA Growth Rate falls into.

NeoPharm Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

NeoPharm Co (XKRX:092730) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

NeoPharm Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoPharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510

Website

http://www.neopharm.co.kr

NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co Headlines

No Headlines